Evidence map›Paper›PMID 33526983›Full record

ReviewInternational journal of medical sciences2021

Src-family Protein Tyrosine Kinases: A promising target for treating Cardiovascular Diseases.

Yuhong Zhai, Jun Yang, Jing Zhang, Jian Yang, Qi Li, Tao Zheng

Open access · goldAbstract readReview
In one paragraph

Review in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Angiotensin-Converting Enzyme Inhibitory Peptide Derived from UltrafineJournal of agricultural and food chemistry · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Protective Role of Endothelial Fibulin-4 in Valvulo-Arterial Integrity.Journal of the American Heart Association · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yuhong ZhaiDepartment of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China.
Jun YangDepartment of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China.
Jing ZhangInstitute of Cardiovascular Diseases, China Three Gorges University, Yichang 443000, China.
Jian YangDepartment of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China.
Qi LiDepartment of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China.
Tao ZhengDepartment of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China.
China Three Gorges University · CNYichang Central People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Src-family protein tyrosine kinases (SFKs), a subfamily of non-receptor tyrosine kinases, are ubiquitously expressed in various cell types. Numerous studies have suggested that SFKs are related to signal transduction in major cardiac physiological and pathological processes, it is the activity of SFKs that is connected with the maintenance of cardiovascular homeostasis. Upon stimulation of various injury factors or stress, the phosphorylation state of SFKs is changed, which has been found to modulate different cardiac pathological conditions, such as hypertension, coronary heart disease, ischemic heart disease, myocardial ischemia-reperfusion injury, arrhythmia and cardiomyopathy via regulating cell growth, differentiation, movement and function, electrophysiologic signals. This review summarizes the basic information about SFKs, updates its role in the different processes underlying the development of multiple cardiovascular diseases (CVDs), and highlights their potential role as disease biomarkers and therapeutic targets, which would help understand the pathophysiology of CVDs and promote the further potential clinical adhibition.

Indexed as

BiomarkersCardiovascular DiseasesHumansPhosphorylationProtein Kinase InhibitorsSignal Transductionsrc-Family KinasesBiomarkersProtein Kinase Inhibitorssrc-Family Kinasescoronary heart diseasehypertensionischemic heart diseasemyocardial ischemia reperfusion injurySrc-family protein tyrosine kinases

Identifiers

PMID33526983
PMCPMC7847615
OpenAlexW3128656238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.